A detailed history of Compass Capital Management, Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Compass Capital Management, Inc holds 260 shares of LLY stock, worth $199,617. This represents 0.02% of its overall portfolio holdings.

Number of Shares
260
Previous 260 -0.0%
Holding current value
$199,617
Previous $235,000 2.13%
% of portfolio
0.02%
Previous 0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$592.2 - $792.28 $153,972 - $205,992
260 New
260 $202,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Compass Capital Management, Inc Portfolio

Follow Compass Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compass Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Compass Capital Management, Inc with notifications on news.